Files and links (2)
Interaction of Candida albicans with human gut epithelium in the presence of Live Biotherapeutic Products (LBPs)952.57 kB
Published VersionCC BY-NC-ND V4.0, Open Access
Journal article
Interaction of Candida albicans with human gut epithelium in the presence of Live Biotherapeutic Products (LBPs)
Microbiology Australia, Vol.42(3), pp.120-124
2021
Abstract
Candida albicans is a semi-ubiquitous pathobiont that is known to significantly impact human health and wellbeing, causing a significant financial strain on the medical system. Due to increasing antifungal resistance, there is a growing need for novel fungal therapeutics to treat diseases caused by this fungus. The development and use of Live Biotherapeutic Products (LBPs) is an innovative and novel approach to potentially treating Candidiasis and other comorbidities associated with C. albicans infection. To evaluate their anti-pathogenic efficacy, it is necessary to understand the underlying mechanisms involved, via the use of biomimetic cell models. In this study, six LBPs were chosen to investigate their competitive inhibitory effect against C. albicans using a co-culture of Caco-2 cells and mucous-secreting HT29-MTX cells to mimic human gut epithelium. The LBP strains were supplied by Servatus Biopharmaceuticals and identified as SVT 01D1, SVT 04P1, SVT 05P2, SVT 06B1, SVT 07R1 and SVT 08Z1. Five out of the six LBPs showed a significant reduction in the adhesion of C. albicans and all six LBPs reduced C. albicans invasion in the co-culture cells to varying degrees. There was no significant difference between co-inoculation of C. albicans with the LBPs or pre-inoculation of LBPs before the addition of C. albicans. The potential of these LBPs as novel anti-fungal therapeutics for the treatment of C. albicans diseases can be further documented in clinical trials.
Details
- Title
- Interaction of Candida albicans with human gut epithelium in the presence of Live Biotherapeutic Products (LBPs)
- Authors
- Bronwyn Smit (Author) - University of the Sunshine Coast, Queensland, School of Health and Behavioural Sciences - LegacyAnna Kuballa (Author) - University of the Sunshine Coast, Queensland, School of Health and Behavioural Sciences - LegacySamantha Coulson (Author) - Servatus BiopharmaceuticalsMohammad Katouli (Author) - University of the Sunshine Coast, Queensland, GeneCology Research Centre - Legacy
- Publication details
- Microbiology Australia, Vol.42(3), pp.120-124
- Publisher
- C S I R O Publishing
- Date published
- 2021
- DOI
- 10.1071/MA21035
- ISSN
- 2201-9189; 1324-4272
- Copyright note
- Copyright (c) The Authors 2021. Open Access CC BY-NC-ND, published (by CSIRO Publishing) on behalf of the ASM
- Organisation Unit
- School of Health - Biomedicine; University of the Sunshine Coast, Queensland; School of Science, Technology and Engineering; Centre for Bioinnovation; School of Health and Behavioural Sciences - Legacy
- Language
- English
- Record Identifier
- 99569201002621
- Output Type
- Journal article
Metrics
5 File views/ downloads
29 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Web Of Science research areas
- Microbiology
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites